Telomium Email Formats
Biotechnology Research • 
Ivry-sur-Seine, Île-de-France, France • 1-10 Employees
Key Contact at Telomium
Guillaume Kellermann
Founder & CEO
Company overview
| Headquarters | 9 RUE ROBESPIERRE, IVRY SUR SEINE, 94200, FR |
| Website | |
| Keywords | Cancer, Oncology, Immunotherapy, Telomerase |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
About Telomium
Telomium is a biotechnology company developing a therapeutic product for cancer immunotherapy. Our first-in-class ribonucleoprotein vaccine has the ability to mimic a viral attack and induce an auto-immune reaction targeted against any form of cancer, without causing significant side effects. This self-vectored and self-adjuvanted vaccine is prepared from a patented, safe, competitive and scalable yeast-based technology using a breakthrough innovation in the production of recombinant telomerase. Today, we are actively looking for funding to finance a Clinical Phase I/Phase II trial in humans.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Telomium has 1 employees across 1 departments.
Departments
Number of employees
Telomium Tech Stack
Discover the technologies and tools that power Telomium's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
Web servers
Font scripts
Programming languages
Blogs
Hosting
SSL/TLS certificate authorities
Databases
Miscellaneous
Performance
United Arab Emirates
Denmark
Nigeria
United Kingdom
Australia
United StatesFrequently asked questions
4.8
40,000 users
